HSCT recipients had lower odds of mortality in both cohorts (p > 0.05), although this difference did not reach statistical significance.
← all excerpts
Factors Associated With Mortality in Leukemia and Lymphoma With COVID-19: A National Inpatient Sample Analysis (2020-2021).
1
—
—